{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T13:14:03Z","timestamp":1770470043046,"version":"3.49.0"},"reference-count":103,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.bioorg.2024.107827","type":"journal-article","created":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T12:26:07Z","timestamp":1726662367000},"page":"107827","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Unveiling the anti-cancer potentiality of phthalimide-based Analogues targeting tubulin polymerization in MCF-7 cancerous Cells: Rational design, chemical Synthesis, and Biological-coupled Computational investigation"],"prefix":"10.1016","volume":"153","author":[{"given":"Ateyatallah","family":"Aljuhani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed S.","family":"Nafie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nader R.","family":"Albujuq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wafa","family":"Hourani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fawzia F.","family":"Albelwi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khaled M.","family":"Darwish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aya","family":"Samir Ayed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Reda Aouad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadjet","family":"Rezki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2024.107827_b0005","doi-asserted-by":"crossref","unstructured":"F. Bray, M. Laversanne, H. Sung, J. Ferlay, R.L. Siegel, I. Soerjomataram, A. Jemal, Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA: Cancer J. Clin. 74 (2024) 229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834.","DOI":"10.3322\/caac.21834"},{"key":"10.1016\/j.bioorg.2024.107827_b0010","doi-asserted-by":"crossref","unstructured":"Wang, Y. and Minden, A., Current molecular combination therapies used for the treatment of breast cancer. Int. J. Mol. Sci., 23(19) (2022), p.11046. https:\/\/doi.org\/10.3390%2Fijms231911046.","DOI":"10.3390\/ijms231911046"},{"key":"10.1016\/j.bioorg.2024.107827_b0015","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1517\/14656566.2014.885952","article-title":"The emergence of targeted drugs in breast cancer to prevent resistance to endocrine treatment and chemotherapy","volume":"15","author":"Austreid","year":"2014","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.bioorg.2024.107827_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1568011023354290","article-title":"Mechanism of Action of Antitumor Drugs that Interact with Microtubules and Tubulin","volume":"2","author":"Jordan","year":"2012","journal-title":"Curr. Med. Chem. Anticancer Agents"},{"key":"10.1016\/j.bioorg.2024.107827_b0025","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejmech.2014.09.051","article-title":"Recent developments in tubulin polymerization inhibitors: An overview","volume":"87","author":"Kaur","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107827_b0030","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.3390\/biom12121843","article-title":"Recent Advances of Tubulin Inhibitors Targeting the Colchicine Binding Site for Cancer Therapy","volume":"12","author":"Hawash","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.bioorg.2024.107827_b0035","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1158\/1535-7163.MCT-09-0366","article-title":"Microtubule inhibitors: Differentiating tubulin-inhibiting agents based on mechanisms of action, clinical activity, and resistance","volume":"8","author":"Perez","year":"2009","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bioorg.2024.107827_b0040","doi-asserted-by":"crossref","unstructured":"B. Karahalil, S. Yard\u0131m-Akaydin, S. Nacak Baytas, An overview of microtubule targeting agents for cancer therapy, J. Ind. Hyg. Toxicol. 70 (2019) 160\u2013172. https:\/\/doi.org\/10.2478\/aiht-2019-70-3258.","DOI":"10.2478\/aiht-2019-70-3258"},{"key":"10.1016\/j.bioorg.2024.107827_b0045","first-page":"1","article-title":"Microtubule Organization Is Essential for Maintaining Cellular Morphology and Function","volume":"2022","author":"Huang","year":"2022","journal-title":"Oxid. Med. Cell Longev."},{"key":"10.1016\/j.bioorg.2024.107827_b0050","doi-asserted-by":"crossref","first-page":"34653","DOI":"10.1038\/srep34653","article-title":"A Novel Resveratrol Based Tubulin Inhibitor Induces Mitotic Arrest and Activates Apoptosis in Cancer Cells","volume":"6","author":"Thomas","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2024.107827_b0055","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.3390\/molecules28041948","article-title":"Pyrrolyldihydropyrazino[1,2-a]indoletrione Analogue Microtubule Inhibitor Induces Cell-Cycle Arrest and Apoptosis in Colorectal Cancer Cells","volume":"28","author":"Yang","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2024.107827_b0060","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1007\/s11095-012-0828-z","article-title":"An overview of tubulin inhibitors that interact with the colchicine binding site","volume":"29","author":"Lu","year":"2012","journal-title":"Pharm. Res."},{"key":"10.1016\/j.bioorg.2024.107827_b0065","first-page":"82","article-title":"Resistance to anti-tubulin agents: From vinca alkaloids to epothilones","volume":"2","author":"Krause","year":"2019","journal-title":"Cancer Drug Resist."},{"key":"10.1016\/j.bioorg.2024.107827_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111691","article-title":"Indole: A privileged scaffold for the design of anti-cancer agents","volume":"183","author":"Wan","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107827_b0075","doi-asserted-by":"crossref","unstructured":"F. Naaz, F. Ahmad, B.A. Lone, Y.R. Pokharel, N.K. Fuloria, S. Fuloria, M. Ravichandran, L. Pattabhiraman, S. Shafi, M. Shahar Yar, Design and synthesis of newer 1,3,4-oxadiazole and 1,2,4-triazole based Topsentin analogues as antiproliferative agent targeting tubulin, Bioorg. Chem. 95 (2020) 103519. https:\/\/doi.org\/10.1016\/j.bioorg.2019.103519.","DOI":"10.1016\/j.bioorg.2019.103519"},{"key":"10.1016\/j.bioorg.2024.107827_b0080","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s11030-015-9616-0","article-title":"Design, synthesis, in vitro cytotoxic activity evaluation, and apoptosis-induction study of new 9(10H)-acridinone-1,2,3-triazoles","volume":"19","author":"Mohammadi-Khanaposhtani","year":"2015","journal-title":"Mol. Divers."},{"key":"10.1016\/j.bioorg.2024.107827_b0085","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00894-017-3403-z","article-title":"Structural and inhibition analysis of novel sulfur-rich 2-mercaptobenzothiazole and 1,2,3-triazole ligands against Mycobacterium tuberculosis DprE1 enzyme","volume":"23","author":"Karan","year":"2017","journal-title":"J. Mol. Model."},{"key":"10.1016\/j.bioorg.2024.107827_b0090","doi-asserted-by":"crossref","unstructured":"F. Naaz, M.C. Preeti Pallavi, S. Shafi, N. Mulakayala, M. Shahar Yar, H.M. Sampath Kumar, 1,2,3-triazole tethered Indole-3-glyoxamide derivatives as multiple inhibitors of 5-LOX, COX-2 & tubulin: Their antiproliferative & anti-inflammatory activity, Bioorg. Chem. 81 (2018) 1\u201320. https:\/\/doi.org\/10.1016\/j.bioorg.2018.07.029.","DOI":"10.1016\/j.bioorg.2018.07.029"},{"key":"10.1016\/j.bioorg.2024.107827_b0095","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.carres.2007.10.021","article-title":"A novel domino-click approach for the synthesis of sugar based unsymmetrical bis-1,2,3-triazoles","volume":"343","author":"Arora","year":"2008","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.bioorg.2024.107827_b0100","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/ardp.201400398","article-title":"Design and Synthesis of Novel 1,2,3-Triazole- and 2-Isoxazoline-Based Bis -Heterocycles as Immune Potentiators","volume":"348","author":"Ismail","year":"2015","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.bioorg.2024.107827_b0105","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.ejmech.2013.10.032","article-title":"Synthesis of novel 1,2,3-triazole based benzoxazolinones: Their TNF-\u03b1 based molecular docking with in-vivo anti-inflammatory, antinociceptive activities and ulcerogenic risk evaluation","volume":"70","author":"Haider","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107827_b0110","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1016\/j.bmc.2019.07.005","article-title":"1,2,3-Triazole-containing hybrids as leads in medicinal chemistry: A recent overview","volume":"27","author":"Bozorov","year":"2019","journal-title":"Bioorg. & Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107827_b0115","doi-asserted-by":"crossref","unstructured":"S.G. Agalave, S.R. Maujan, V.S. Pore, Click Chemistry: 1,2,3\u2010Triazoles as Pharmacophores, Chem.: Asian J. 6 (2011) 2696\u20132718. https:\/\/doi.org\/10.1002\/asia.201100432.","DOI":"10.1002\/asia.201100432"},{"key":"10.1016\/j.bioorg.2024.107827_b0120","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2174\/2212796814999200807214519","article-title":"A Recent Review on Drug Modification Using 1,2,3-triazole","volume":"14","author":"Sahu","year":"2020","journal-title":"Curr. Chem. Biol."},{"key":"10.1016\/j.bioorg.2024.107827_b0125","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/j.drudis.2017.05.014","article-title":"The 1,2,3-triazole ring as a bioisostere in medicinal chemistry","volume":"22","author":"Bonandi","year":"2017","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bioorg.2024.107827_b0130","doi-asserted-by":"crossref","first-page":"2100158","DOI":"10.1002\/ardp.202100158","article-title":"1,2,3-Triazole hybrids as anti-cancer agents: A review","volume":"355","author":"Alam","year":"2022","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.bioorg.2024.107827_b0135","doi-asserted-by":"crossref","unstructured":"H.H. Al-hujaj, F.A. Almashal, A.T. Kadum, M.K. Mohammed, K.A. Hussein, A.M. Jassem, Click Chemistry-Based Synthesis of Novel 1,2,3-Triazole Derivatives and Cytotoxic Activity on Breast and Prostate Cancer Cell Lines: http:\/\/www.doi.org\/10.26538\/tjnpr\/v7i7.6, Trop. J. Nat. Prod. Res. 7 (2023) 3306\u20133313.","DOI":"10.26538\/tjnpr\/v7i7.6"},{"key":"10.1016\/j.bioorg.2024.107827_b0140","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1124\/pr.117.013755","article-title":"Small-Molecule Screens: A Gateway to Cancer Therapeutic Agents with Case Studies of Food and Drug Administration-Approved Drugs","volume":"69","author":"Coussens","year":"2017","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bioorg.2024.107827_b0145","doi-asserted-by":"crossref","first-page":"252","DOI":"10.2174\/1570179417666200325124712","article-title":"Advances in Synthesis and Medicinal Applications of Compounds Derived from Phthalimide","volume":"17","author":"Almeida","year":"2020","journal-title":"Curr. Org. Synth."},{"key":"10.1016\/j.bioorg.2024.107827_b0150","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1080\/00397911.2018.1440602","article-title":"Synthesis and antibacterial evaluation of nitrogen containing novel heterocyclic chalcones","volume":"48","author":"Kaushik","year":"2018","journal-title":"Synth. Commun."},{"key":"10.1016\/j.bioorg.2024.107827_b0155","doi-asserted-by":"crossref","first-page":"1700363","DOI":"10.1002\/ardp.201700363","article-title":"Design, synthesis, biological evaluations, molecular docking, and in vivo studies of novel phthalimide analogs","volume":"351","author":"Zahran","year":"2018","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.bioorg.2024.107827_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bioorg.2016.03.003","article-title":"Synthesis, characterization, molecular modeling, and potential antimicrobial and anti-cancer activities of novel 2-aminoisoindoline-1,3-dione derivatives","volume":"66","author":"Ahmed","year":"2016","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2024.107827_b0165","article-title":"Discovery of novel phthalimide analogs: synthesis, antimicrobial and antitubercular screening with molecular docking studies, EXCLI Journal; 15:Doc781","volume":"1611\u20132156","author":"Rateb","year":"2016","journal-title":"ISSN"},{"key":"10.1016\/j.bioorg.2024.107827_b0170","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1016\/j.bmc.2017.04.027","article-title":"Synthesis and biological activity of new phthalimides as potential anti-inflammatory agents","volume":"25","author":"Bach","year":"2017","journal-title":"Bioorg. & Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107827_b0175","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1016\/j.bmc.2008.02.005","article-title":"Synthesis and anti-cancer activity of benzothiazole containing phthalimide on human carcinoma cell lines","volume":"16","author":"Kok","year":"2008","journal-title":"Bioorg. & Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107827_b0180","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1007\/s00044-016-1693-9","article-title":"Amino acid derivatives. Part 6. Synthesis, in vitro antiviral activity and molecular docking study of new N-\u03b1-amino acid derivatives conjugated spacer phthalimide backbone","volume":"25","author":"Al-Masoudi","year":"2016","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2024.107827_b0185","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.2174\/1389557520666200905125738","article-title":"From Antibacterial to Antitumour Agents: A Brief Review on The Chemical and Medicinal Aspects of Sulfonamides","volume":"20","author":"Azevedo-Barbosa","year":"2020","journal-title":"Mini-Rev. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107827_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2020.129148","article-title":"Design, synthesis, DNA binding, modeling, anti-cancer studies and DFT calculations of Schiff bases tethering benzothiazole-1,2,3-triazole conjugates","volume":"1225","author":"Almehmadi","year":"2021","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2024.107827_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2020.129192","article-title":"Design, click conventional and microwave syntheses, DNA binding, docking and anti-cancer studies of benzotriazole-1,2,3-triazole molecular hybrids with different pharmacophores","volume":"1225","author":"Alraqa","year":"2021","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2024.107827_b0200","doi-asserted-by":"crossref","first-page":"16048","DOI":"10.3390\/molecules200916048","article-title":"Synthesis of Novel 2,5-Disubstituted-1,3,4-thiadiazoles Clubbed 1,2,4-Triazole, 1,3,4-Thiadiazole, 1,3,4-Oxadiazole and\/or Schiff Base as Potential Antimicrobial and Antiproliferative Agents","volume":"20","author":"Rezki","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2024.107827_b0205","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.3390\/molecules23112788","article-title":"Design, Synthesis and Anti-cancer Screening of Novel Benzothiazole-Piperazine-1,2,3-Triazole Hybrids","volume":"23","author":"Aouad","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2024.107827_b0210","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.molstruc.2019.04.005","article-title":"Design, click synthesis, anti-cancer screening and docking studies of novel benzothiazole-1,2,3-triazoles appended with some bioactive benzofused heterocycles","volume":"1188","author":"Aouad","year":"2019","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2024.107827_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103446","article-title":"Introducing of acyclonucleoside analogues tethered 1,2,4-triazole as anti-cancer agents with dual epidermal growth factor receptor kinase and microtubule inhibitors","volume":"94","author":"Aouad","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2024.107827_b0220","doi-asserted-by":"crossref","first-page":"11347","DOI":"10.1002\/slct.202003296","article-title":"DNA Binding, Docking, and Anti-cancer Studies of Novel Bis-1,2,3-triazoles Phthalonitrile","volume":"5","author":"Yahya Alraqa","year":"2020","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.bioorg.2024.107827_b0225","doi-asserted-by":"crossref","unstructured":"A. Al Sheikh Ali, D. Khan, A. Naqvi, F.F. Al-blewi, N. Rezki, M.R. Aouad, M. Hagar, Design, Synthesis, Molecular Modeling, Anti-cancer Studies, and Density Functional Theory Calculations of 4-(1,2,4-Triazol-3-ylsulfanylmethyl)-1,2,3-triazole Derivatives, ACS Omega 6 (2021) 301\u2013316. https:\/\/doi.org\/10.1021\/acsomega.0c04595.","DOI":"10.1021\/acsomega.0c04595"},{"key":"10.1016\/j.bioorg.2024.107827_b0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.arabjc.2021.102997","article-title":"Microwave versus conventional synthesis, anti-cancer, DNA binding and docking studies of some 1,2,3-triazoles carrying benzothiazole","volume":"14","author":"Aljuhani","year":"2021","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.bioorg.2024.107827_b0235","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.3390\/ijms22031162","article-title":"Design and Synthesis of Novel Imidazole Derivatives Possessing Triazole Pharmacophore with Potent Anti-cancer Activity, and In Silico ADMET with GSK-3\u03b2 Molecular Docking Investigations","volume":"22","author":"Al-blewi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2024.107827_b0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104835","article-title":"Design of molecular hybrids of phthalimide-triazole agents with potent selective MCF-7\/HepG2 cytotoxicity: Synthesis, EGFR inhibitory effect, and metabolic stability","volume":"111","author":"Ihmaid","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2024.107827_b0245","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/nature01600","article-title":"Dynamics and mechanics of the microtubule plus end","volume":"422","author":"Howard","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2024.107827_b0250","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.3390\/cells8101294","article-title":"Tubulin: Structure, Functions and Roles in Disease","volume":"8","author":"Binarov\u00e1","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.bioorg.2024.107827_b0255","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.3390\/cells9112356","article-title":"The Tubulin Code in Mitosis and Cancer","volume":"9","author":"Lopes","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.bioorg.2024.107827_b0260","doi-asserted-by":"crossref","first-page":"12363","DOI":"10.1038\/s41598-018-30376-y","article-title":"Indibulin dampens microtubule dynamics and produces synergistic antiproliferative effect with vinblastine in MCF-7 cells: Implications in cancer chemotherapy","volume":"8","author":"Kapoor","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2024.107827_b0265","doi-asserted-by":"crossref","unstructured":"M. Podolak, S. Holota, Y. Deyak, K. Dziduch, R. Dudchak, M. Wujec, K. Bielawski, R. Lesyk, A. Bielawska, Tubulin inhibitors. Selected scaffolds and main trends in the design of novel anti-cancer and antiparasitic agents, Bioorg. Chem. 143 (2024) 107076. https:\/\/doi.org\/10.1016\/j.bioorg.2023.107076.","DOI":"10.1016\/j.bioorg.2023.107076"},{"key":"10.1016\/j.bioorg.2024.107827_b0270","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.3390\/biomedicines11071856","article-title":"FGF1 Protects MCF-7 Cells against Taltobulin through Both the MEKs\/ERKs and PI3K\/AKT Signaling Pathway","volume":"11","author":"Szymczyk","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.bioorg.2024.107827_b0275","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.3390\/ph16071000","article-title":"Antiproliferative and Tubulin-Destabilising Effects of 3-(Prop-1-en-2-yl)azetidin-2-Ones and Related Compounds in MCF-7 and MDA-MB-231 Breast Cancer Cells","volume":"16","author":"Wang","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bioorg.2024.107827_b0280","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.jmb.2017.01.001","article-title":"Insights into the Distinct Mechanisms of Action of Taxane and Non-Taxane Microtubule Stabilizers from Cryo-EM Structures","volume":"429","author":"Kellogg","year":"2017","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bioorg.2024.107827_b0285","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/1873-3468.14003","article-title":"The high-resolution X-ray structure of vinca-domain inhibitors of microtubules provides a rational approach for drug design","volume":"595","author":"Chengyong","year":"2021","journal-title":"FEBS Letters"},{"key":"10.1016\/j.bioorg.2024.107827_b0290","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1002\/mog2.46","article-title":"Microtubule-targeting agents for cancer treatment: Seven binding sites and three strategies","volume":"2","author":"Wang","year":"2023","journal-title":"Med. Comm.\u2013oncology"},{"key":"10.1016\/j.bioorg.2024.107827_b0295","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/ph13010008","article-title":"Colchicine-Binding Site Inhibitors from Chemistry to Clinic: A Review","volume":"13","author":"McLoughlin","year":"2020","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bioorg.2024.107827_b0300","first-page":"5650","article-title":"Microtubule Targeting Agents in Disease: Classic Drugs","volume":"13","author":"Wordeman","year":"2021","journal-title":"Novel Roles, Cancers"},{"key":"10.1016\/j.bioorg.2024.107827_b0305","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/med.21541","article-title":"Antitubulin sulfonamides: The successful combination of an established drug class and a multifaceted target","volume":"39","author":"Vicente-Bl\u00e1zquez","year":"2019","journal-title":"Med. Res. Reviews"},{"key":"10.1016\/j.bioorg.2024.107827_b0310","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/cmdc.201100361","article-title":"The Tubulin Colchicine Domain: a Molecular Modeling Perspective","volume":"7","author":"Massarotti","year":"2012","journal-title":"Chem. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107827_b0315","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.2174\/1568026614666141130092637","article-title":"New Ligands of the Tubulin Colchicine Site Based on X-Ray Structures","volume":"14","author":"Alvarez","year":"2014","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107827_b0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.116106","article-title":"The microtubule cytoskeleton: A validated target for the development of 2-Aryl-1H-benzo[d]imidazole derivatives as potential anti-cancer agents","volume":"171","author":"Park","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bioorg.2024.107827_b0325","first-page":"4360","article-title":"Application of ensemble pharmacophore-based virtual screening to the discovery of novel antimitotic tubulin inhibitors, Comput. Struct","volume":"19","author":"Gallego-Yerga","year":"2021","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.bioorg.2024.107827_b0330","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1124\/mol.118.114801","article-title":"Colchicine Binding Site Agent DJ95 Overcomes Drug Resistance and Exhibits Antitumor Efficacy","volume":"96","author":"Arnst","year":"2019","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bioorg.2024.107827_b0335","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/febs.13555","article-title":"Structures of a diverse set of colchicine binding site inhibitors in complex with tubulin provide a rationale for drug discovery","volume":"283","author":"Wang","year":"2016","journal-title":"The FEBS Journal"},{"key":"10.1016\/j.bioorg.2024.107827_b0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2023.117194","article-title":"The most common linkers in bioactive molecules and their bioisosteric replacement network","volume":"81","author":"Ertl","year":"2023","journal-title":"Bioorg. & Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107827_b0345","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1002\/ddr.21805","article-title":"Discovery of novel indole-1,2,4-triazole derivatives as tubulin polymerization inhibitors","volume":"82","author":"Wu","year":"2021","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.bioorg.2024.107827_b0350","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.3390\/biomedicines11113078","article-title":"Synthesis, Cytotoxic, and Computational Screening of Some Novel Indole\u20131,2,4-Triazole-Based S-Alkylated N-Aryl Acetamides","volume":"11","author":"Zahoor","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.bioorg.2024.107827_b0355","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13065-022-00887-x","article-title":"Design, synthesis and evaluation of novel 1,2,4-triazole derivatives as promising anti-cancer agents","volume":"16","author":"Emami","year":"2022","journal-title":"BMC Chemistry"},{"key":"10.1016\/j.bioorg.2024.107827_b0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116597","article-title":"Indole derivatives as tubulin polymerization inhibitors for the development of promising anti-cancer agents","volume":"55","author":"Hong","year":"2022","journal-title":"Bioorg. & Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107827_b0365","doi-asserted-by":"crossref","first-page":"2286939","DOI":"10.1080\/14756366.2023.2286939","article-title":"3-aryl-4-(3,4,5-trimethoxyphenyl)pyridines inhibit tubulin polymerisation and act as anti-cancer agents","volume":"39","author":"Wang","year":"2024","journal-title":"J Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107827_b0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113629","article-title":"Design, synthesis and biological evaluation of indole-based [1,2,4]triazolo[4,3-a] pyridine derivatives as novel microtubule polymerization inhibitors","volume":"223","author":"Wu","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107827_b0375","doi-asserted-by":"crossref","unstructured":"V. Yele, S.K.S.S. Pindiprolu, S. Sana, D.S.V.N.M. Ramamurty, J.R.K. Madasi, S. Vadlamani, Synthesis and Preclinical Evaluation of Indole Triazole Conjugates as Microtubule Targeting Agents that are Effective against MCF-7 Breast Cancer Cell Lines, Anti-Cancer Agents Med. Chem. 21 (2021) 1047\u20131055. https:\/\/doi.org\/10.2174\/1871520620666200925102940.","DOI":"10.2174\/1871520620666200925102940"},{"key":"10.1016\/j.bioorg.2024.107827_b0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113533","article-title":"Tuning the activity of known drugs via the introduction of halogen atoms, a case study of SERT ligands \u2013 Fluoxetine and fluvoxamine","volume":"220","author":"Staro\u0144","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107827_b0385","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1021\/ar400103r","article-title":"The Halogen Bond in the Design of Functional Supramolecular Materials: Recent Advances","volume":"46","author":"Priimagi","year":"2013","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.bioorg.2024.107827_b0390","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1021\/acscentsci.8b00718","article-title":"Drug-Membrane Permeability across Chemical Space","volume":"5","author":"Menichetti","year":"2019","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.bioorg.2024.107827_b0395","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nrd4163","article-title":"The role of ligand efficiency metrics in drug discovery","volume":"13","author":"Hopkins","year":"2014","journal-title":"Nat. Rev. Drug. Discov."},{"key":"10.1016\/j.bioorg.2024.107827_b0400","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/nrd2445","article-title":"The influence of drug-like concepts on decision-making in medicinal chemistry","volume":"6","author":"Leeson","year":"2007","journal-title":"Nat. Rev. Drug. Discov."},{"key":"10.1016\/j.bioorg.2024.107827_b0405","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1016\/j.ddtec.2010.11.003","article-title":"Ligand efficiency as a guide in fragment hit selection and optimization","volume":"7","author":"Schultes","year":"2010","journal-title":"Drug Discov. Today: Technologies"},{"key":"10.1016\/j.bioorg.2024.107827_b0410","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1021\/ci7004093","article-title":"Structure\u2212Activity Landscape Index: Identifying and Quantifying Activity Cliffs","volume":"48","author":"Guha","year":"2008","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bioorg.2024.107827_b0415","doi-asserted-by":"crossref","first-page":"21869","DOI":"10.1039\/D1NJ03892C","article-title":"Discovery of new indole-based 1,2,4-triazole derivatives as potent tubulin polymerization inhibitors with anti-cancer activity","volume":"45","author":"Yang","year":"2021","journal-title":"New J. Chem."},{"key":"10.1016\/j.bioorg.2024.107827_b0420","doi-asserted-by":"crossref","first-page":"1004835","DOI":"10.3389\/fchem.2022.1004835","article-title":"Design, synthesis and biological evaluation of 9-aryl-5H-pyrido[4,3-b]indole derivatives as potential tubulin polymerization inhibitors","volume":"10","author":"Shi","year":"2022","journal-title":"Front. Chem."},{"key":"10.1016\/j.bioorg.2024.107827_b0425","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nature02393","article-title":"Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain","volume":"428","author":"Ravelli","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2024.107827_b0430","doi-asserted-by":"crossref","first-page":"29448","DOI":"10.1021\/acsomega.3c02979","article-title":"Effect of Colchicine Binding Site Inhibitors on the Tubulin Intersubunit Interaction","volume":"8","author":"Sargsyan","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.bioorg.2024.107827_b0435","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.drudis.2021.12.001","article-title":"Molecular interactions at the colchicine binding site in tubulin: An X-ray crystallography perspective","volume":"27","author":"Wang","year":"2022","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bioorg.2024.107827_b0440","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1021\/jm0302997","article-title":"Evaluation of Docking Performance: Comparative Data on Docking Algorithms","volume":"47","author":"Kontoyianni","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107827_b0445","doi-asserted-by":"crossref","unstructured":"K.E. Shearwin, S.N. Timasheff, Effect of colchicine analogs on the dissociation of .alpha..beta. tubulin into subunits: The locus of colchicine binding, Biochem. 33 (1994) 894\u2013901. https:\/\/doi.org\/10.1021\/bi00170a007.","DOI":"10.1021\/bi00170a007"},{"key":"10.1016\/j.bioorg.2024.107827_b0450","doi-asserted-by":"crossref","DOI":"10.2174\/1386207320666170509151253","article-title":"Structural Investigation of Vinca Domain Tubulin Binders by Pharmacophore, Atom based QSAR, Docking and Molecular Dynamics Simulations","volume":"20","author":"Athar","year":"2017","journal-title":"Comb. Chem. High Throughput Screen."},{"key":"10.1016\/j.bioorg.2024.107827_b0455","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/aps.2014.34","article-title":"Tubulin inhibitors: pharmacophore modeling, virtual screening and molecular docking","volume":"35","author":"Niu","year":"2014","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bioorg.2024.107827_b0460","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.3390\/molecules27051587","article-title":"Indole-Based Tubulin Inhibitors: Binding Modes and SARs Investigations","volume":"27","author":"Tang","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2024.107827_b0465","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.bpj.2015.01.001","article-title":"Minimalistic Predictor of Protein Binding Energy: Contribution of Solvation Factor to Protein Binding","volume":"108","author":"Choi","year":"2015","journal-title":"Biophys. J."},{"key":"10.1016\/j.bioorg.2024.107827_b0470","doi-asserted-by":"crossref","first-page":"e1003072","DOI":"10.1371\/journal.pcbi.1003072","article-title":"Quantifying the Molecular Origins of Opposite Solvent Effects on Protein-Protein Interactions","volume":"9","author":"Vagenende","year":"2013","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.bioorg.2024.107827_b0475","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13065-018-0479-1","article-title":"Design, synthesis, ADME prediction and pharmacological evaluation of novel benzimidazole-1,2,3-triazole-sulfonamide hybrids as antimicrobial and antiproliferative agents","volume":"12","author":"Al-blewi","year":"2018","journal-title":"Chem. Cent. J."},{"key":"10.1016\/j.bioorg.2024.107827_b0480","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.bioorg.2024.107827_b0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112847","article-title":"Development of triazolothiadiazine derivatives as highly potent tubulin polymerization inhibitors: Structure-activity relationship, in vitro and in vivo study","volume":"208","author":"Ma","year":"2020","journal-title":"Eur. J. Med. Chem"},{"key":"10.1016\/j.bioorg.2024.107827_b0490","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/cbdd.13997","article-title":"Quinoline-based thiazolidinone derivatives as potent cytotoxic and apoptosis-inducing agents through EGFR inhibition","volume":"99","author":"Nafie","year":"2022","journal-title":"Chem. Biol. Drug. Des."},{"key":"10.1016\/j.bioorg.2024.107827_b0495","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bioorg.2024.107827_b0500","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.4155\/fmc.15.71","article-title":"Carbonic anhydrase IX inhibitors in cancer therapy: an update","volume":"7","author":"Supuran","year":"2015","journal-title":"Fut. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107827_b0505","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10822-010-9352-6","article-title":"Ligand docking and binding site analysis with PyMOL and Autodock\/Vina","volume":"24","author":"Seeliger","year":"2010","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.bioorg.2024.107827_b0510","doi-asserted-by":"crossref","first-page":"2200188","DOI":"10.1002\/minf.202200188","article-title":"Speed vs Accuracy: Effect on Ligand Pose Accuracy of Varying Box Size and Exhaustiveness in AutoDock Vina","volume":"42","author":"Agarwal","year":"2023","journal-title":"Mol. Inform."},{"key":"10.1016\/j.bioorg.2024.107827_b0515","doi-asserted-by":"crossref","unstructured":"S.O. Albuquerque, T.G. Barros, L.R.S. Dias, C.H. da S. Lima, P.H.R. de A. Azevedo, L.A.P. Flores-Junior, E.G. Dos Santos, H.F. Loponte, S. Pinheiro, W.B. Dias, E.M.F. Muri, A.R. Todeschini, Biological evaluation and molecular modeling of peptidomimetic compounds as inhibitors for O-GlcNAc transferase (OGT), Eur. J. Pharm. Sci. 154 (2020) 105510. https:\/\/doi.org\/10.1016\/j.ejps.2020.105510.","DOI":"10.1016\/j.ejps.2020.105510"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824007326?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824007326?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T02:23:12Z","timestamp":1738203792000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206824007326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":103,"alternative-id":["S0045206824007326"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107827","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unveiling the anti-cancer potentiality of phthalimide-based Analogues targeting tubulin polymerization in MCF-7 cancerous Cells: Rational design, chemical Synthesis, and Biological-coupled Computational investigation","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107827","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107827"}}